Blastic Plasmacytoid Dendritic Cell Neoplasm: Update on Molecular Biology, Diagnosis, and Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasms

(2014) Fanny Julia et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients

(2014) A. E. Frankel et al.   BLOOD

Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5-Azacytidine

(2014) Kamel Laribi et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition

(2014) M R Sapienza et al.   LEUKEMIA

Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm

(2014) Nikhil A Sangle et al.   MODERN PATHOLOGY

Mycosis Fungoides

(2013) Sophie X. Song et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

TET2mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow

(2013) Khaled Alayed et al.   AMERICAN JOURNAL OF HEMATOLOGY

Diagnostic and Therapeutic Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm: A Focus on Hematopoietic Cell Transplantation

(2013) Mohamed A. Kharfan-Dabaja et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

L-asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm

(2013) Bérengère Gruson et al.   BRITISH JOURNAL OF HAEMATOLOGY

CLTC-ALKfusion as a primary event in congenital blastic plasmacytoid dendritic cell neoplasm

(2013) Kiriko Tokuda et al.   GENES CHROMOSOMES & CANCER

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study

(2013) L. Pagano et al.   HAEMATOLOGICA

Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

(2013) J Menezes et al.   LEUKEMIA

Characterization of CD56+ Dendritic-Like Cells: A Normal Counterpart of Blastic Plasmacytoid Dendritic Cell Neoplasm?

(2013) Yohei Osaki et al.   PLoS One

Expression of CD31/PECAM-1 (Platelet Endothelial Cell Adhesion Molecule 1) by Blastic Plasmacytoid Dendritic Cell Neoplasms

(2013) Katrin A. Salva et al.   JAMA Dermatology

Specific Skin Lesions in Chronic Myelomonocytic Leukemia

(2012) Franck Vitte et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Blastic plasmacytoid dendritic cell neoplasm: a single-center experience

(2012) Ho Jung An et al.   ANNALS OF HEMATOLOGY

SPIB, a novel immunohistochemical marker for human blastic plasmacytoid dendritic cell neoplasms: characterization of its expression in major hematolymphoid neoplasms

(2012) S. Montes-Moreno et al.   BLOOD

Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation

(2012) D. Roos-Weil et al.   BLOOD

Unrelated SCT induces long-term remission in patients with blastic plasmacytoid dendritic cell neoplasm

(2012) M Unteregger et al.   BONE MARROW TRANSPLANTATION

Sequential combination of high dose methotrexate andl-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasm

(2012) Lila Gilis et al.   LEUKEMIA & LYMPHOMA

Blastic plasmacytoid dendritic cell neoplasm: is it time to redefine the standard of care?

(2012) Pier Paolo Piccaluga et al.   Expert Review of Hematology

Plasmacytoid Dendritic Cells: Recent Progress and Open Questions

(2011) Boris Reizis et al.   Annual Review of Immunology

Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC) in Elderly Patients: Results of a Treatment Algorithm Employing Allogeneic Stem Cell Transplantation with Moderately Reduced Conditioning Intensity

(2011) Sascha Dietrich et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion

(2011) M. Lucioni et al.   BLOOD

Therapeutic Effect of Lenalidomide in a Novel Xenograft Mouse Model of Human Blastic NK Cell Lymphoma/Blastic Plasmacytoid Dendritic Cell Neoplasm

(2011) A. Agliano et al.   CLINICAL CANCER RESEARCH

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review

(2011) Michael J. Rauh et al.   LEUKEMIA RESEARCH

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications

(2010) A. G. Jegalian et al.   HAEMATOLOGICA

Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: Case report and review of the literature

(2010) Yang Li et al.   PATHOLOGY RESEARCH AND PRACTICE

Plasmacytoid Dendritic Cells

(2009) Armin G. Jegalian et al.   ADVANCES IN ANATOMIC PATHOLOGY

Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?

(2009) S. Dalle et al.   BRITISH JOURNAL OF DERMATOLOGY

Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia

(2009) Francine Garnache-Ottou et al.   BRITISH JOURNAL OF HAEMATOLOGY

Alterations of the Cell-Cycle Inhibitors p27KIP1 and p16INK4a Are Frequent in Blastic Plasmacytoid Dendritic Cell Neoplasms

(2009) Thomas Wiesner et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Novel markers of normal and neoplastic human plasmacytoid dendritic cells

(2008) T. Marafioti et al.   BLOOD

Natural killer cell neoplasms

(2008) Xiayuan Liang et al.   CANCER

Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-α via toll-like receptor 9

(2008) J. R. Tversky et al.   CLINICAL AND EXPERIMENTAL ALLERGY

CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate

(2008) Justin J. Leitenberger et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY